-
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
(PAR-22-085)
National Cancer Institute
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)
(PAR-22-086)
National Cancer Institute
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)
(PAR-22-117)
National Eye Institute
Application Receipt Date(s): March 31, 2022
-
Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed)
(RFA-AG-23-005)
National Institute on Aging
Application Receipt Date(s): July 1, 2022
-
In utero Treatments of Congenital Dental and Craniofacial Disorders Using Precision Medicine Approaches (R01 Clinical Trial Not Allowed)
(RFA-DE-23-004)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): June 14, 2022
-
In utero Treatments of Congenital Dental and Craniofacial Disorders Using Precision Medicine Approaches (R21 Clinical Trial Not Allowed)
(RFA-DE-23-005)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): June 14, 2022
-
Retail Food Safety Regulatory Association Collaboration (U18) [Clinical Trial Not Allowed]
(RFA-FD-22-008)
Food and Drug Administration
Application Receipt Date(s): April 22, 2022 by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54, Basic Experimental Studies Involving Humans Allowed)
(RFA-NS-22-019)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Heart, Lung, and Blood Institute
National Center for Complementary and Integrative Health
Application Receipt Date(s): May 24, 2022
-
Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24 Basic Experimental Studies with Humans Required)
(RFA-NS-22-020)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Heart, Lung, and Blood Institute
National Center for Complementary and Integrative Health
Application Receipt Date(s): May 24, 2022
-
Emergency Awards: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)
(RFA-OD-22-005)
Office of the Director, NIH
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Application Receipt Date(s): May 2, 2022
-
Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)
(RFA-OD-22-006)
Office of the Director, NIH
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Application Receipt Date(s): May 2, 2022
-
Limited Competition: Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Optional)
(RFA-RM-22-001)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): May 23, 2022
-
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)
(RFA-RM-22-008)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): July 12, 2022